Cargando…
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
The arrival of targeted therapies has presented both a conceptual and a practical challenge in the treatment of patients with advanced non-small cell lung carcinomas (NSCLCs). The relationship of these treatments with specific histologies and predictive biomarkers has made the handling of biopsies t...
Autores principales: | Conde, E., Angulo, B., Izquierdo, E., Paz-Ares, L., Belda-Iniesta, C., Hidalgo, M., López-Ríos, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695315/ https://www.ncbi.nlm.nih.gov/pubmed/23359174 http://dx.doi.org/10.1007/s12094-012-0983-z |
Ejemplares similares
-
Overview of a chemoresponse assay in ovarian cancer
por: Grendys, E. C., et al.
Publicado: (2014) -
The clinical value of cardiopulmonary exercise testing in the modern era
por: Laveneziana, Pierantonio, et al.
Publicado: (2021) -
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2019) -
Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018) -
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
por: Rosenzweig, Erika B., et al.
Publicado: (2019)